A case of sternal osteomyelitis during treatment with everolimus for recurrent breast cancer

BACKGROUND: Everolimus is a mechanistic-target-of-rapamycin (mTOR) inhibitor bearing a potent antitumor effect against hormone receptor-positive breast cancer. Here, we report the case of a patient with recurrent breast cancer who developed osteomyelitis during the treatment with everolimus plus exe...

Descripción completa

Detalles Bibliográficos
Autores principales: Abe, Kaori, Shimoda, Masafumi, Yoshinami, Tetsuhiro, Sota, Yoshiaki, Miyake, Tomohiro, Tanei, Tomonori, Kagara, Naofumi, Naoi, Yasuto, Shimazu, Kenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799826/
https://www.ncbi.nlm.nih.gov/pubmed/35089453
http://dx.doi.org/10.1186/s40792-022-01376-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799826/
https://www.ncbi.nlm.nih.gov/pubmed/35089453
http://dx.doi.org/10.1186/s40792-022-01376-y

Ejemplares similares